VEGFA and hypertensive disorder: Although the overall burden of toxicity was similar with different regimens, the incidence of specific toxicities observed varied with different TKI partners (VEGF/Multitargeted; Hypertension; Oncogene targeted TKIs; Rash, irAEs) and there was a high degree of heterogeneity between studies.